Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) has been shown to interact with ACE2 receptors on myocytes and vascular endothelial cells leading to infection and progression of COVID19.
With advances in ultra-sensitive Simoa digital biomarker detection technology, a broad menu of assays are now available to measure biomarkers of neurodegeneration, axonal damage and neuroinflammation at baseline levels in both CSF and blood at fg/ml concentrations. Download the app note to learn more.